Thurston Springer Miller Herd & Titak’s 10x Genomics TXG Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$383	Hold	10	–	–	﹤0.01%	1209
2026 Q1	$212	Hold	10	–	–	﹤0.01%	1304
2025 Q4	$163	Buy	+10	New	+$151	﹤0.01%	1348
2025 Q3	–	Sell	-10	Closed	-$115	–	1298
2025 Q2	$115	Hold	10	–	–	﹤0.01%	1618
2025 Q1	$87	Hold	10	–	–	﹤0.01%	1660
2024 Q4	$143	Sell	10 -2	-17%	-$32	﹤0.01%	1312
2024 Q3	$270	Hold	12	–	–	﹤0.01%	1497
2024 Q2	$232	Buy	+12	New	+$314	﹤0.01%	1486

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's TXG Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its 10x Genomics (TXG) position steady in Q2 2026 at 10 shares worth $383. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Thurston Springer Miller Herd & Titak first reported a position in TXG in Q2 2024 and has held it in 8 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Thurston Springer Miller Herd & Titak held 10 shares of 10x Genomics worth $383 as of Q2 2026.
Thurston Springer Miller Herd & Titak left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1209 holding.
Thurston Springer Miller Herd & Titak first reported a position in 10x Genomics in Q2 2024 and has held it in 8 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.